by Amruth Sundarkumar | Jul 14, 2022 | Asian Dollar Bonds, Corporates
Jubilant Pharma Ltd has announced that its subsidiary Jubilant Pharma Holdings Inc (JPHI) will raise a $400mn loan from Standard Chartered Bank. It will be the 5Y loan of which $350mn will be used for repayment of existing term loan and bonds while the remaining $50mn...
by Megha Malhotra | Aug 26, 2021 | High Yield Bonds, India
Indian pharmaceutical company Jubilant Pharma won approval from 63.93% of holders of its $200mn 6% bonds due 2024 to waive certain conditions related to a planned reorganization, as per IFR. Jubilant will pay $2 per $1,000 in principal to the holders that gave their...
by bondevalue | Feb 23, 2021 | Credit Ratings, India
S&P has upgraded Jubilant Pharma to BB from BB- with a stable outlook on expectations of stronger financial position. The rating action comes close on the heels of a similar upgrade by Fitch on February 18. After the demerger of the company’s parent Jubilant...
by bondevalue | Feb 19, 2021 | High Yield Bonds, India
The credit rating of India’s Jubilant Pharma Limited (JPL) has been upgraded to BB from BB- by Fitch on the back of improvements in its business profile. The rating action comes as the Life Science Ingredient (LSI) business of its parent Jubilant Pharmova Ltd...
